Now Available – My archived interview on Social Media in Pharma with Paul Chaney – feel free to forward the link (http://bit.ly/29kAoN) to your colleagues. TODAY’S NEWS BMS/Astra diabetes drug …
Today’s Top Pharma News 71309
Finally - FDA approves DSI/Lilly blood thinner Effient. Narrow indication with warnings, however - The approval makes Lilly's Effient the first real competition to the blood thinner Plavix, the …
Today’s Top Three in Pharma 042309
FDA extends review of AstraZeneca/BMS experimental diabetes drug Onglyza. Teva blocked from launching generic form of Lilly's Evista; also rumored to be eyeballing a purchase of …
Today’s Top Three in Pharma 041009
J&J cutting 900 positions, mostly in sales - Diversified healthcare company Johnson & Johnson said on Thursday it was eliminating 900 positions from its Ortho-McNeil-Janssen Pharmaceutical …
Today’s Top Three in Pharma 040809
Will pharma sales reps be able to go after overtime pay? According to a CT court, the answer is yes - Without getting too technical, at the core of the ruling is the fact that Pharmaceutical Sale …
Today’s Top Three in Pharma 030409
Teva's Copaxone approved for preventative treament of MS - The drug is already approved to treat relapsing-remitting multiple sclerosis, where new symptoms occur suddenly or older symptoms become …